María José Echarri

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial

Eva Ciruelos, Patricia Villagrasa, Tomás Pascual et al. · Clinical Cancer Research · 2020 · 113 citations

Medicine, Oncology, Pharmacology +17

HER2/ <i>neu</i> testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

Carlos Gómez-Martín, Elena Garralda, María José Echarri et al. · Journal of Clinical Pathology · 2012 · 92 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +13

The NER-related gene <i>GTF2H5</i> predicts survival in high-grade serous ovarian cancer patients

Javier Machín Gayarre, Marta Kamieniak, Iván Muñoz‐Repeto et al. · Journal of Gynecologic Oncology · 2015 · 29 citations · Full text

Medicine, Molecular Biology, Oncology +17

Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer

Luís Manso, Fernando Moreno, Rosario Mayorga Márquez et al. · Current Oncology · 2015 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17